ArticleCurrent neuropharmacology2022

A Preliminary Nuclear Magnetic Resonance Metabolomics Study Identifies Metabolites that Could Serve as Diagnostic Markers of Major Depressive Disorder.

Ibrahim Mohammed Badamasi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.